INTERPACE BIOSCIENCES INC (IDXG)
IDXG moved a median of 0.00% 30 minutes after news, and +1.03% by the close. How IDXG actually reacts to news — the realized, point-in-time move the market made, measured across 87 labeled events over the last three years with zero look-ahead.
IDXG’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 80 |
| 30-min | 0.00% | 48% | 80 |
| 60-min | 0.00% | 44% | 82 |
| to close | +1.03% | 64% | 80 |
| Middle 50% of IDXG reactions | -0.86% to +3.07% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 87 |
Half of all INTERPACE BIOSCIENCES INC news events land between -0.86% and +3.07% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when IDXG moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to IDXG's baseline. Nothing else.
Recent IDXG events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K INTERPACE BIOSCIENCES, For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.04% | |
| Interpace Biosciences Announces Preliminary Unaudited Third Quarter 2026 Revenue | Press release | GlobeNewswire | +0.00% | -2.04% | |
| Form S-1/A INTERPACE BIOSCIENCES, | SEC filing · Form S-1 | SEC EDGAR | — | — | |
| Form 8-K INTERPACE BIOSCIENCES, For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K/A INTERPACE BIOSCIENCES, For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | — | +0.69% | |
| Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting | Press release | GlobeNewswire | — | — | |
| Form 8-K INTERPACE BIOSCIENCES, For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | +1.32% | +0.85% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Aug 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form DEF 14A INTERPACE BIOSCIENCES, For: Jul 07 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -0.92% | |
| Form DEFA14A INTERPACE BIOSCIENCES, | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -0.92% | |
| Form PREM14A INTERPACE BIOSCIENCES, For: Jun 24 | SEC filing · Form PREM14A | SEC EDGAR | +0.00% | -2.96% | |
| Form PRE 14A INTERPACE BIOSCIENCES, For: Jun 23 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +1.19% | |
| Form 8-K INTERPACE BIOSCIENCES, For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +1.16% | +1.16% | |
| Form 10-Q INTERPACE BIOSCIENCES, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.37% | -7.32% | |
| Interpace Biosciences Announces First Quarter 2026 Financial and Business Results | Press release | GlobeNewswire | -1.37% | -7.32% | |
| Form 10-K/A INTERPACE BIOSCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.50% | +6.00% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | -0.52% | +0.91% | |
| Form 10-K INTERPACE BIOSCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.71% | +8.00% | |
| Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results | Press release | GlobeNewswire | +1.71% | +8.00% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Jan 20 | SEC filing · Form 8-K | SEC EDGAR | +10.53% | +34.59% | |
| Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure | Press release | GlobeNewswire | +10.53% | +34.59% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners | Press release | GlobeNewswire | +0.00% | +5.56% | |
| Form 10-Q INTERPACE BIOSCIENCES, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -4.67% | — | |
| Form 8-K INTERPACE BIOSCIENCES, For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -4.67% | — | |
| Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results | Press release | GlobeNewswire | -4.67% | — | |
| Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting | Press release | GlobeNewswire | +1.76% | +1.76% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.53% | |
| Form 10-Q INTERPACE BIOSCIENCES, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +2.41% | |
| Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results | Press release | GlobeNewswire | +0.00% | +2.41% | |
| Form 10-Q INTERPACE BIOSCIENCES, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.46% | -1.32% | |
| Form 8-K INTERPACE BIOSCIENCES, For: May 08 | SEC filing · Form 8-K | SEC EDGAR | -0.46% | -1.32% | |
| Interpace Biosciences Announces First Quarter 2025 Financial and Business Results | Press release | GlobeNewswire | -0.46% | -1.32% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-K/A INTERPACE BIOSCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -10.34% | |
| Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Press release | GlobeNewswire | +0.00% | -27.78% | |
| Form 10-K INTERPACE BIOSCIENCES, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -2.15% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.85% | |
| Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results | Press release | GlobeNewswire | +4.28% | -6.31% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Jan 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +12.93% | |
| PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan | Press release | GlobeNewswire | +2.04% | +30.87% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.26% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -22.98% | |
| Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Press release | GlobeNewswire | -41.46% | -58.54% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.06% | |
| Form 10-Q INTERPACE BIOSCIENCES, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -8.59% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +1.19% | +3.17% | |
| Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results | Press release | GlobeNewswire | +8.43% | +20.08% | |
| Form D INTERPACE BIOSCIENCES, | SEC filing · Form D | SEC EDGAR | +10.08% | +20.97% | |
| Form 8-K INTERPACE BIOSCIENCES, For: Oct 10 | SEC filing · Form 8-K | SEC EDGAR | +3.96% | +22.77% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the IDXG section they belong to.
Where else IDXG is measured.
IDXG earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VIVOS INC (RDGL) | 88 | 0.00% | 43% |
| AMBU A S UNSP/ADR (AMBBY) | 87 | 0.00% | 13% |
| Organovo Holdings, Inc. (ONVO) | 87 | -0.95% | 37% |
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is INTERPACE BIOSCIENCES INC's median reaction calculated?
Every labeled IDXG news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 87 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of IDXG's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does IDXG's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.